PRIA Logo™
Title 42, The Public Health and WelfareRelease 119-73not60

§300aa–23 Trial

Title 42 › Chapter 6A— PUBLIC HEALTH SERVICE › Subchapter XIX— VACCINES › Part 2— National Vaccine Injury Compensation Program › Subpart b— additional remedies › § 300aa–23

Last updated Apr 5, 2026|Official source

Summary

Civil lawsuits against vaccine makers for injury or death from a vaccine given after October 1, 1988 must be tried in three stages, unless the claim is barred by section 300aa–11(a)(2). The first stage decides if the maker is legally liable under section 300aa–22. The second stage decides how much money (not including punitive damages) the maker must pay if found liable. If the plaintiff asks, a third stage decides any punitive damages. A maker that proves it followed, in all important ways, the rules under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 301 et seq.) and this chapter for that vaccine cannot be punished with punitive damages unless it committed fraud, intentionally hid safety or effectiveness information during approval under section 262 or after approval, or did other criminal or illegal acts related to vaccine safety. At any stage, the Vaccine Injury Table, findings or legal conclusions from the U.S. Court of Federal Claims or a special master on a petition under section 300aa–11, and the Court of Federal Claims’ final judgment and its appeals in that petition cannot be used as evidence.

Full Legal Text

Title 42, §300aa–23

The Public Health and Welfare, Source: USLM XML via OLRC

(a)A civil action against a vaccine manufacturer for damages for a vaccine-related injury or death associated with the administration of a vaccine after October 1, 1988, which is not barred by section 300aa–11(a)(2) of this title shall be tried in three stages.
(b)The first stage of such a civil action shall be held to determine if a vaccine manufacturer is liable under section 300aa–22 of this title.
(c)The second stage of such a civil action shall be held to determine the amount of damages (other than punitive damages) a vaccine manufacturer found to be liable under section 300aa–22 of this title shall be required to pay.
(d)(1)If sought by the plaintiff, the third stage of such an action shall be held to determine the amount of punitive damages a vaccine manufacturer found to be liable under section 300aa–22 of this title shall be required to pay.
(2)If in such an action the manufacturer shows that it complied, in all material respects, with all requirements under the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 301 et seq.] and this chapter applicable to the vaccine and related to the vaccine injury or death with respect to which the action was brought, the manufacturer shall not be held liable for punitive damages unless the manufacturer engaged in—
(A)fraud or intentional and wrongful withholding of information from the Secretary during any phase of a proceeding for approval of the vaccine under section 262 of this title,
(B)intentional and wrongful withholding of information relating to the safety or efficacy of the vaccine after its approval, or
(C)other criminal or illegal activity relating to the safety and effectiveness of vaccines,
(e)In any stage of a civil action, the Vaccine Injury Table, any finding of fact or conclusion of law of the United States Court of Federal Claims or a special master in a proceeding on a petition filed under section 300aa–11 of this title and the final judgment of the United States Court of Federal Claims and subsequent appellate review on such a petition shall not be admissible.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

References in Text

The Federal Food, Drug, and Cosmetic Act, referred to in subsec. (d)(2), is act
June 25, 1938, ch. 675, 52 Stat. 1040, which is classified generally to chapter 9 (§ 301 et seq.) of Title 21, Food and Drugs. For complete classification of this Act to the Code, see Tables. Codification In subsec. (a), “
October 1, 1988” substituted for “the

Effective Date

of this subpart” on authority of section 323 of Pub. L. 99–660, as amended, set out as an

Effective Date

note under section 300aa–1 of this title.

Amendments

1992—Subsec. (e). Pub. L. 102–572 substituted “United States Court of Federal Claims” for “United States Claims Court” in two places. 1989—Subsec. (e). Pub. L. 101–239 substituted “finding of fact or conclusion of law” for “finding”, “special master” for “master appointed by such court”, and directed substitution of “the United States Claims Court and subsequent appellate review” for “a district court of the United States” which was executed by inserting “and subsequent appellate review” after “the United States Claims Court” the second place it appeared to reflect the probable intent of Congress and the amendment by Pub. L. 100–203, § 4307(a), see 1987 Amendment note below. 1987—Subsec. (a). Pub. L. 100–203, § 4302(b)(1), substituted “

Effective Date

of this subpart” for “

Effective Date

of this part”. Subsec. (e). Pub. L. 100–203, § 4307(9), substituted “the United States Claims Court” for “a district court of the United States” in two places.

Statutory Notes and Related Subsidiaries

Effective Date

of 1992 AmendmentAmendment by Pub. L. 102–572 effective Oct. 29, 1992, see section 911 of Pub. L. 102–572, set out as a note under section 171 of Title 28, Judiciary and Judicial Procedure.

Effective Date

of 1989 AmendmentFor applicability of

Amendments

by Pub. L. 101–239 to petitions filed after Dec. 19, 1989, petitions currently pending in which the evidentiary record is closed, and petitions currently pending in which the evidentiary record is not closed, with provision for an immediate suspension for 30 days of all pending cases, see section 6601(s)(1) of Pub. L. 101–239, set out as a note under section 300aa–10 of this title.

Reference

Citations & Metadata

Citation

42 U.S.C. § 300aa–23

Title 42, The Public Health and Welfare

Last Updated

Apr 5, 2026

Release point: 119-73not60